您的位置: 首页 > 农业专利 > 详情页

RET9 and VEGFR2 inhibitors
专利权人:
Inc.;Kala Pharmaceuticals
发明人:
NOWAK, Pawel Wojciech,ONG, Winston Zapanta
申请号:
AU2018351520
公开号:
AU2018351520A1
申请日:
2018.10.19
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
Provided herein are compounds, compositions, and pharmaceutical compositions of Formula (I). Also provided herein are methods of using compounds of Formula (I) to treat proliferative diseases, ocular diseases, dermatological diseases, inflammatory diseases, autoimmune diseases, autoinflammatory diseases, and metabolic diseases. Also provided herein are methods of using the compounds of Formula (I) as therapeutics, e.g., in the treatment and/or prevention of diseases associated with growth factor activity or angiogenesis. In some embodiments, the disease being treated is a proliferative disease.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充